Management of Apolipoprotein B (ApoB)-Related Pancreatitis

Acute Management Phase

• The American College of Clinical Nutrition recommends treating acute pancreatitis according to severity, regardless of etiology, with appropriate fluid resuscitation and pain management 1
• Implement specific management for hypertriglyceridemia concurrently with standard pancreatitis care, as recommended by the Clinical Nutrition guidelines 1
• For mild pancreatitis, initiate oral feeding if tolerated; if not tolerated, begin enteral nutrition (EN), as suggested by the Clinical Nutrition guidelines 1
• For moderate to severe pancreatitis, initiate early enteral nutrition (within 24-72 hours of admission) via nasogastric or nasojejunal tube, according to the Clinical Nutrition recommendations 1
• Administer IV insulin for both glucose and triglyceride control in patients with hyperglycemia, as recommended by the Clinical Nutrition guidelines 1, 2
• Monitor blood glucose hourly until stable, then every 2-4 hours, as suggested by the Praxis Medical Insights guidelines 3
• Target blood glucose levels in the 150-200 mg/dL range during insulin infusion, according to the Praxis Medical Insights recommendations 2
• Administer IV insulin with heparin, with careful monitoring, in patients without hyperglycemia, as recommended by the Clinical Nutrition guidelines 1, 2
• Consider plasmapheresis if triglycerides remain significantly elevated despite insulin therapy, as suggested by the Clinical Nutrition guidelines 1
• Avoid lipid-containing parenteral nutrition during acute management, as recommended by the Praxis Medical Insights guidelines 2
• Monitor and correct hypocalcemia, which is common and associated with worse outcomes, according to the Praxis Medical Insights guidelines 2

Nutritional Support During Acute Phase

• Enteral nutrition is preferred over parenteral nutrition when possible, as recommended by the Clinical Nutrition guidelines 1, 4
• If intra-abdominal pressure (IAP) >15 mmHg, initiate EN via nasojejunal route starting at 20 mL/h, increasing according to tolerance, as suggested by the Clinical Nutrition guidelines 1
• If IAP >20 mmHg or abdominal compartment syndrome develops, temporarily stop EN and initiate parenteral nutrition, according to the Clinical Nutrition recommendations 1
• If EN is not tolerated or inadequate to meet nutritional requirements, supplement with or switch to parenteral nutrition, as recommended by the Clinical Nutrition guidelines 1

Long-Term Management

• First-line pharmacological therapy for long-term triglyceride control is fibrates, as recommended by the Clinical Nutrition guidelines 1
• Second-line pharmacological therapy is omega-3 fatty acids, according to the Clinical Nutrition guidelines 1
• Add a statin if hypercholesterolemia is present, as recommended by the Clinical Nutrition guidelines 1
• Implement strict dietary modifications, including reducing dietary fat to 10-15% of total calories, as suggested by the Praxis Medical Insights guidelines 2
• Eliminate added sugars and alcohol, according to the Praxis Medical Insights recommendations 2

Special Considerations

• Continuing lipid-containing parenteral nutrition during acute management can worsen hypertriglyceridemia, as recommended by the Praxis Medical Insights guidelines 2
• Overfeeding during parenteral nutrition can exacerbate hyperglycemia and worsen outcomes, according to the Clinical Nutrition guidelines 5
• Abrupt discontinuation of insulin can lead to rebound hyperglycemia, as recommended by the Praxis Medical Insights guidelines 2